![]() |
Results Reported For Exploratory Phase 2 Study Of Nexavar In Combination With Chemoth
Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) announced results from a randomized, placebo-controlled Phase 2 trial sponsored by Northwestern University.
More... |
| All times are GMT -7. The time now is 03:19 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021